Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ogbe A. et al, (2021), Nature Communications, 12

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Payne RP. et al, (2021), Cell

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22

MAIT cell activation augments adenovirus vector vaccine immunogenicity

Provine NM. et al, (2021), Science, 371, 521 - 526

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

Thompson CP. et al, (2020), Eurosurveillance, 25

Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis

Slevin SM. et al, (2020), Journal of Crohn's and Colitis, 14, 1446 - 1461

Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.

Sasson SC. et al, (2020), Clinical and experimental immunology

MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.

Esposito I. et al, (2020), Science translational medicine, 12

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.

Cicconi P. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70, 2073 - 2081

MAIT Cells in Health and Disease.

Provine NM. and Klenerman P., (2020), Annual review of immunology, 38, 203 - 228

Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.

Atcheson E. et al, (2020), Hepatology (Baltimore, Md.), 71, 794 - 807

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus.

Fawsitt CG. et al, (2020), Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 23, 180 - 190

Local heroes or villains: tissue-resident memory T cells in human health and disease.

Sasson SC. et al, (2020), Cell Mol Immunol

Human MAIT Cell Activation In Vitro.

Hagel JP. et al, (2020), Methods in molecular biology (Clifton, N.J.), 2098, 97 - 124

HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model

McNaughton AL. et al, (2019), BMC Medicine, 17

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.

Luo J. et al, (2019), The Journal of allergy and clinical immunology, 144, 1722 - 1726.e10

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).

Cossarizza A. et al, (2019), European journal of immunology, 49, 1457 - 1973

Immunotherapy-related hepatitis: real-world experience from a tertiary centre

Cheung V. et al, (2019), Frontline Gastroenterology, 10, 364 - 371

Prolonged evolution of virus-specific memory T cell immunity after severe avian influenza A (H7N9) virus infection

Zhao M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1045 - 1045

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?